Japan Lifeline : Announces Changes in Organization and Personnel(107KB)
May 23, 2024 at 11:45 am IST
Share
May 23, 2024
To whom it may concern,
Company: Japan Lifeline Co., Ltd.
Representative: Keisuke Suzuki, President and CEO (Code: 7575 TSE Prime Market)
Contact person: Takeyoshi Egawa, Vice President, Senior Manager of Business Administration Department TEL. +81-3-6711-5200)
Japan Lifeline Announces Changes in Organizations and Personnel
Japan Lifeline Co., Ltd. announced that at the board of directors meeting held today, it has decided to make the following changes to its organizations and personnel.
Changes in the organization structure (Effective on July 1, 2024)
Newly establish Overseas Business Promotion Division under General Business Headquarters.
Changes in personnel (Effective on July 1, 2024)
New position and title
Name
Old position and title
Senior Operating Officer,
Senior Operating Officer,
Associate Executive Manager of R&D
Senior Manager of Ichihara R&D and
and Manufacturing Headquarters,
Kunio Kuwahara
Manufacturing Department of R&D and
Senior Manager of Ichihara R&D and
Manufacturing Headquarters
Manufacturing Department
Operating Officer,
Operating Officer,
Deputy Executive Manager of CVG
Nobuo Takahashi
Associate Executive Manager of CVG
Business Unit, General Manager of
Business Unit
Overseas Business Promotion Division
Attachments
Original Link
Original Document
Permalink
Disclaimer
JLL - Japan Lifeline Co. Ltd. published this content on
23 May 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
23 May 2024 06:14:07 UTC.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
